<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We report on a 17-month-old African girl with cutaneous and ophthalmologic features of oculocutaneous <z:hpo ids='HP_0001022'>albinism</z:hpo> type 2 as well as <z:hpo ids='HP_0000252'>microcephaly</z:hpo>, <z:hpo ids='HP_0001344'>absent speech</z:hpo>, and tremulous movements </plain></SENT>
<SENT sid="1" pm="."><plain>Mutations of the P gene within the Angelman/Prader-Willi syndrome critical region at 15q11-q13 cause oculocutaneous <z:hpo ids='HP_0001022'>albinism</z:hpo> type 2 </plain></SENT>
<SENT sid="2" pm="."><plain>Comorbid oculocutaneous <z:hpo ids='HP_0001022'>albinism</z:hpo> and <z:e sem="disease" ids="C0162635" disease_type="Disease or Syndrome" abbrv="">Angelman syndrome</z:e> were suspected and confirmed by cytogenetics </plain></SENT>
<SENT sid="3" pm="."><plain>Phenotypic features of <z:e sem="disease" ids="C0162635" disease_type="Disease or Syndrome" abbrv="">Angelman syndrome</z:e> or Prader-Willi syndrome in a patient with <z:hpo ids='HP_0001022'>albinism</z:hpo> should prompt further investigation </plain></SENT>
</text></document>